Business Daily Media

Business Marketing

.

Fujitsu and PeptiDream Achieve Milestone in Joint Research for Peptide Drug Candidates with High-Speed, High-Precision Exploration Technology

  • Written by ACN Newswire - Press Releases

Fujitsu and PeptiDream Achieve Milestone in Joint Research for Peptide Drug Candidates with High-Speed, High-Precision Exploration Technology

KAWASAKI, Japan, Oct 13, 2020 - (JCN Newswire) - Fujitsu Limited and PeptiDream Inc. today announced that the two companies have succeeded in identifying, based on in-silico exploration, stable conformations(1) of a cyclic peptide(2) drug candidate within a 12-hour period. This represents a milestone achieved by utilizing high-performance

Read more //?#

Popular

5 Reasons Why You Shouldn’t Miss out On Visiting Australia

Famous for its fascinating landscapes, breathtaking shores and mesmerizing viewpoints, Australia has easily become one of the top travel destinations in the world. If you’re eager to go to your next adventure and you need to...

Evolt 360 successfully raises $12m to meet strong order pipeline

The company recently raised funds to meet the growing demand for its industry leading body composition scanner and software solution  Evolt 360, the Australian developer of a proprietary body composition scanning technology, ...

Achieving financial freedom with AllianceCorp

AllianceCorp has unveiled their new brand look and vision, as the brand doubles down on their commitment to help everyday Australians achieve financial freedom despite their limitations. Managing Director, Jason Paetow began his...